Cellectis (CLLS) Enterprise Value (2015 - 2026)

Cellectis' Enterprise Value history runs 14 years deep, the most recent figure standing at -$185.7 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 23.81% year-over-year to -$185.7 million; the TTM figure through Mar 2026 stood at -$185.7 million (up 23.81% YoY), while the FY2025 annual figure was -$208.7 million, up 48.87% from the prior year.
• Enterprise Value for Q1 2026 stood at -$185.7 million, up from -$208.7 million in the prior quarter.
• The five-year high for Enterprise Value was -$67.4 million in Q3 2023, with the low at -$408.1 million in Q4 2024.
• The 5-year median for Enterprise Value is -$192.2 million (2025), against an average of -$196.8 million.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value plunged 287.4% in 2024, then soared 48.87% in 2025.
• Cellectis' Enterprise Value stood at -$187.7 million in 2022, then plunged by 83.94% to -$345.2 million in 2023, then slipped by 18.23% to -$408.1 million in 2024, then jumped by 48.87% to -$208.7 million in 2025, then advanced by 11.02% to -$185.7 million in 2026.
• Business Quant data shows CLLS's Enterprise Value at -$185.7 million in Q1 2026, -$208.7 million in Q4 2025, and -$192.2 million in Q3 2025.